AXA Framlington Biotech GBP Z Acc (FUND:B784NS1) - Fund price


Fund Report

AXA Framlington Biotech Fund GBP Z Acc

Morningstar Style Box®

Equity Style

Large, Mid, SmallSize
Value, Blend, Growth
Style
Size
Share Class Size (mil)246.99 GBP
(27/03/2020)
Fund Size (mil)377.37 GBP
(28/02/2020)
Mkt Cap % 29/02/2020
FundCat
Giant10.356.91
Large41.2026.23
Medium23.6636.71
Small19.0428.76
Micro5.741.39
Valuations and Growth Rates 29/02/2020
FundCategory
Price / Earnings14.6821.75
Price/Book3.704.55
Price/Sales3.996.58
Price/Cash Flow10.8314.60
Dividend-Yield Factor0.730.41
Long-Term Projected Earnings Growth7.4710.63
Historical Earnings Growth28.0929.56
Sales Growth11.9311.78
Cash-Flow Growth15.8212.37
Book-Value Growth5.979.63

Asset Allocation % 29/02/2020

Asset Allocation
LongShortNetCat
Stocks94.540.0094.5495.98
Bonds0.000.000.000.00
Cash4.370.244.130.08
Other1.330.001.333.94
World Regions % 29/02/2020
FundCategory
Greater Europe9.368.60
United Kingdom1.062.01
Eurozone5.453.88
Europe - ex Euro2.852.71
Europe - Emerging0.000.00
Africa0.000.00
Middle East0.000.00
Americas85.6787.51
United States85.6786.64
Canada0.000.85
Latin America0.000.01
Greater Asia4.963.89
Japan1.890.86
Australasia0.000.12
Asia - Developed0.000.29
Asia - Emerging3.082.63
Stock Sector Weightings % 29/02/2020
FundCategory
Cyclical0.000.24
Basic Materials--
Consumer Cyclical--
Financial Services-0.24
Real Estate--
Sensitive0.000.92
Communication Services--
Energy--
Industrials-0.21
Technology-0.71
Defensive100.0098.84
Consumer Defensive--
Healthcare100.0098.84
Utilities--

Top 10 Holdings29/02/2020

Assets in Top 10 Holdings %52.15
Total Number of Equity Holdings51
Total Number of Bond Holdings0
NameSectorCountry%
IncreaseDecreaseNew since last portfolio
IncreaseBiogen Inc HealthcareUnited States8.52
DecreaseAmgen Inc HealthcareUnited States8.00
IncreaseRegeneron Pharmaceuticals Inc HealthcareUnited States6.60
IncreaseGilead Sciences Inc HealthcareUnited States6.45
DecreaseAlexion Pharmaceuticals Inc HealthcareUnited States5.05
DecreaseVertex Pharmaceuticals Inc HealthcareUnited States4.37
DecreaseBiomarin Pharmaceutical Inc HealthcareUnited States4.20
DecreaseSeattle Genetics Inc HealthcareUnited States3.36
DecreaseIncyte Corp HealthcareUnited States2.89
DecreaseIllumina Inc HealthcareUnited States2.70
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.